Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. ACN
6. NVDA
7. IBM
8. PRIM
9. SPY
10. DPZ

Go back to Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results

Galmed Pharma (GLMD) Tops Q1 EPS by 7c

May 9, 2018 7:08 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More